What is the present valuation and projected CAGR of the corticosteroids market?
The corticosteroids market size has grown steadily in recent years. It will grow from $5.47 billion in 2024 to $5.7 billion in 2025 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to treatment of inflammatory conditions, autoimmune disorders and immune system suppression, respiratory conditions and asthma management, allergic reactions and dermatological applications, cancer treatment support.
The corticosteroids market size is expected to see strong growth in the next few years. It will grow to $7.24 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to rising incidence of chronic diseases, expanding applications in rheumatology, advancements in drug delivery, geriatric population growth, research and development in corticosteroid therapeutics. Major trends in the forecast period include immunomodulatory effects emphasis, biosimilar market growth, combination therapies development, pediatric-specific formulations, regulatory compliance focus.
Get Your Free Sample of The Global Corticosteroids Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2832&type=smp
What key drivers have fueled the corticosteroids market’s development over the years?
The rising demand for cancer treatment will propel the growth of the corticosteroid market going forward. Cancer treatment encompasses various therapies, such as surgery, chemotherapy, radiation therapy, immunotherapy, and targeted treatments, designed to eradicate cancer cells and alleviate symptoms. The rising demand for cancer treatment is driven by several factors, including increasing cancer incidence, greater awareness and screening, improved access to healthcare, and the availability of supportive care services. By alleviating symptoms and enhancing the tolerability of cancer treatments, corticosteroids lead to improved patient outcomes, thereby supporting the increasing demand for comprehensive cancer care. For instance, in May 2024, the National Health Service (NHS), the UK’s healthcare system, reported that treatment activity reached its highest level of all time, with over 1,400 patients initiating cancer treatment each working day. Between April 2023 and March 2024, nearly 340,000 individuals received their first cancer treatment. Therefore, rising demand for cancer treatment drives the growth of the corticosteroid market.
What is the segmentation for the corticosteroids market?
The corticosteroids market covered in this report is segmented –
1) By Product: Glucocorticoids, Mineralocorticoids
2) By Application: Skin Allergies, Rheumatology Indications, Endocrinology, Acute Respiratory Diseases, Other Applications
3) By End User: Hospitals, Clinics, Research Institutes, Other End Users
Subsegments:
1) By Glucocorticoids: Hydrocortisone, Prednisone, Dexamethasone, Methylprednisolone, Triamcinolone, Betamethasone, Other Glucocorticoids
2) By Mineralocorticoids: Fludrocortisone, Aldosterone, Other Mineralocorticoids
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/corticosteroid-global-market-report
Who are the most influential companies in the corticosteroids market?
Major companies operating in the corticosteroids market include McKesson Corporation, Pfizer Inc., Johnson and Johnson Services Inc., Merck & Co.Inc., Bayer AG, Sumitomo Corporation, Novartis International AG., Sanofi SA, Bristol Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy’s Laboratories Ltd., Endo International plc, Lupin Limited, Mallinckrodt Pharmaceuticals Ltd., LEO Pharma A/S, Glenmark Pharmaceuticals Ltd., Wockhardt Limited, Indivior plc, Zizhu Pharmaceutical Co. Ltd., Allergan plc, Hikma Pharmaceuticals plc
How will evolving trends contribute to the growth of the corticosteroids market?
The development of silicones for topical and transdermal drug delivery is one of the key trends in the corticosteroid therapy market. Silicone gel sheets are soft wound covers composed of cross-linked polymers reinforced with or bonded to mesh or fabric. A new strategy to deliver drugs to the inner ear from dexamethasone (DXM)-loaded silicone implants and to evaluate the distribution of the drug in the cochlea with confocal microscopy and the development of a new device for local corticosteroids delivery into the oval window with an extended drug release of DXM to the inner ear is also seen in recent years. Silicone gel sheeting is also an excellent treatment option for pediatric patients who may not be able to tolerate intralesional corticosteroid injection. Silicone-based pressure-sensitive adhesives for transdermal drug delivery have shown higher diffusivity and greater skin permeation rate. Silicones offer several advantages such as improved drug permeability, and high diffusivity and offer efficient function and performance to modern drug products.
Which geographic trends are shaping the corticosteroids market, and which region has the highest market share?
North America was the largest region in the corticosteroids therapy market share in 2024. Middle East is expected to be the largest growing region in the global corticosteroids market during the forecast period. The regions covered in the corticosteroids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Corticosteroids Market Report 2025 Offer?
The corticosteroids market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Corticosteroids therapy refers to a treatment that is given in a variety of ways to stifle the immune system and reduce inflammation. Asthma is one of the disorders they are used to treat allergy symptoms such as hay fever, and urticaria (hives). Corticosteroids, sometimes known as steroids, are a kind of anti-inflammatory medication.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2832
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
